TVRD
Tvardi Therapeutics, Inc. Common Stock
TVRD
TVRD
134 hedge funds and large institutions have $315M invested in Tvardi Therapeutics, Inc. Common Stock in 2018 Q4 according to their latest regulatory filings, with 23 funds opening new positions, 46 increasing their positions, 35 reducing their positions, and 31 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
134
Holders Change
-12
Holders Change %
-8.22%
% of All Funds
2.99%
Holding in Top 10
2
Holding in Top 10 Change
-2
Holding in Top 10 Change %
-50%
% of All Funds
0.04%
New
23
Increased
46
Reduced
35
Closed
31
Calls
$4.34M
Puts
$5.68M
Net Calls
-$1.34M
Net Calls Change
-$11.5M
Top Buyers
| 1 |
EMG
ETF Managers Group
Summit,
New Jersey
|
+$7.62M |
| 2 |
Renaissance Technologies
New York
|
+$5.37M |
| 3 |
First Manhattan
New York
|
+$3.64M |
| 4 |
Citigroup
New York
|
+$2.7M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$1.81M |
Top Sellers
| 1 |
NC
Nexthera Capital
New York
|
-$17.7M |
| 2 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$3.11M |
| 3 |
Ameriprise
Minneapolis,
Minnesota
|
-$2.04M |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$1.82M |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$1.56M |
